DexCare is a data-driven intelligence company making access to healthcare easier and better for everyone.
We enable PATIENTS to get the care they need faster, easier, more affordably, with better results.
We enable PROVIDERS to see more patients, easily and more effectively through different modalities.
We enable HEALTH SYSTEMS to utilize resources more efficiently and effectively, lower costs, grow revenue, and build enduring relationships with patients and providers.
DexCare is a series B venture-backed healthtech startup backed by leading healthcare investors. DexCare is led by a customer-focused mission-driven team experienced in building successful, innovative, and transformative solutions to healthcare’s biggest problems. Our company leadership is comprised of healthcare and technology veterans with decades of experience in transformative health systems, healthtech investing, and digital health companies. We work with the world’s largest health systems and provider organizations.
Derek Streat is Founder, CEO and Chairman of DexCare. He is an accomplished healthcare technology entrepreneur and executive, having co-founded and/or been at the earliest stages of six venture-backed companies including C-SATS (acquired by Johnson & Johnson), Classmates (acquired by United Online), Medify (acquired by Alliance Health Networks) and AdReady (acquired by CPXi).
Prior to joining Providence as an Entrepreneur-in-Residence to commercialize the DexCare platform, Derek served as Vice President of Digital Solutions at Johnson & Johnson - a role he assumed after C-SATS was acquired by the world’s largest healthcare company. There he led the charge to transform the organization responsible for training 250,000 surgeons worldwide into a leading healthcare quality improvement and continuous learning institution that directly advanced patient outcomes, provider efficiency, and health system value through digital solutions.
Derek is also actively involved in national healthcare data transparency efforts for the improvement of patient care as a Co-Founder and Board member of two leading data sharing organizations, PEDSnet and the Improving Renal Outcomes Collaborative (IROC).
Sean O’Connor is Co-Founder and Chief Commercialization Officer of DexCare. He is an experienced entrepreneur and executive with a demonstrated history of building high performing technology companies in the health care industry.
Prior to joining Providence as an Entrepreneur-in-Residence to commercialize the DexCare platform, Sean served as Chief Revenue Officer at C-SATS, a healthcare technology platform that was acquired by Johnson & Johnson in 2019. Prior to C-SATS, Sean held a variety of senior roles at Intuitive Surgical helping develop Intuitive into a Fortune 500 company.
Prior to his transition into the healthcare sector he was a combat veteran, graduate of the United States Navel Academy and was a Division 1 basketball player.
Julia Millard is the Chief Customer Experience Officer at DexCare. For almost 20 years, Julia has been introducing new technologies to the healthcare industry, from Epic to point solutions in virtual care and more.
With a deep passion for improving the care experience for patients and providers alike, Julia has helped healthcare systems successfully implement and adopt innovative tools and game-changing systems.
At DexCare, Julia combines her expertise in change management, operational excellence, system workflows, and stakeholder engagement to evolve access to care strategies at healthcare systems across North America. She and her team work closely with all customers to deliver maximum value from the DexCare platform.
Julia currently serves as the President of HIMSS Oregon and holds a BA with honors from the University of Chicago plus an MBA with honors from ESMT in Berlin, Germany. In her spare time, Julia enjoys running the trails in Portland, OR and exploring neighborhood playgrounds with her toddlers.
Chad Waldman heads-up the engineering organization at DexCare; setting the technology strategy and building respected teams to implement DexCare’s vision. With more than 20 years under his belt, Chad has been leading engineering teams with a focus on greenfield technology in both the education and healthcare spaces.
Prior to DexCare’s spin-out, Chad worked at Providence St. Joseph driving much of the solution that makes up DexCare today. He has a passion around fostering talented individuals, working hands-on with coworkers and end users, and jumping at challenges.
In his spare time, you can find him enjoying the outdoors in the Pacific NW with his friends and family and looking for something new to tantalize his taste buds.
Dave Sliwa leads the Data Science team at Dexcare. He brings more than 25 years of experience building data driven SaaS applications. At Dexcare, his organization is repsonsible for all the data and algorithms that power Dexcare’s intelligent decisioning engine along with providing data services to internal and external customers.
Prior to Dexcare, Dave led engineering teams at Classmates.com, Adready.com, and Adobe. He enjoys building and leading teams that build customer facing data services that power business solutions.
Outside of work, Dave enjoys spending time with his family and searching for his golf ball far off the many fairways in Salt Lake City.
Dave Sliwa leads the Data Science team at Dexcare. He brings more than 25 years of experience building data driven SaaS applications. At Dexcare, his organization is repsonsible for all the data and algorithms that power Dexcare’s intelligent decisioning engine along with providing data services to internal and external customers.
Prior to Dexcare, Dave led engineering teams at Classmates.com, Adready.com, and Adobe. He enjoys building and leading teams that build customer facing data services that power business solutions.
Outside of work, Dave enjoys spending time with his family and searching for his golf ball far off the many fairways in Salt Lake City.
Robert heads up all things software reliability, including infrastructure, software testing, technical operations, security, and compliance. With more than 20 years experience, Robert has been leading engineering teams focused within these areas across a number of industries. Prior to DexCare’s spin-out, Robert worked at Providence St. Joseph, focusing on operationalizing the DexCare software stack on Kubernetes and migrating from earlier technologies. He is a technical leader, who loves growing a team of expert engineers and innovating solutions that are multiplying factors for engineering efficiency. You can find Robert always listening to a variety of trance and techno. Outside of work, he dabbles in electronics, and enjoys spending time with his friends and family at the lake or trying some new foods and drinks.
Chris leads DexCare’s Customer Solutions Architecture Team; helping customers bridge business need with the DexCare platform. Chris’ love for technology started as a young child, deconstructing and reconstructing anything electronic he could get his hands on.
Now with over 22 years of experience in enterprise IT systems, network infrastructure, software development, business consulting, and entrepreneurship, this creative passion continues to drive Chris as a technology leader growing a team of talented people to help customers create value with DexCare.
Prior to DexCare’s spin-out, Chris worked at Providence St. Joseph commercializing the solution that makes up DexCare today. before that Chris lead teams delivering enterprise digital solutions for customers in the healthcare and other verticals at Slalom Consulting and his consulting firm Carhea Technologies.
Chris is engaged throughout the entirety of the technology product development process and excels at bridging the gap between the business need and technology solutions. With a deep knowledge of the entire technology stack and business processes, he and his team are instrumental in solution sales.
Born and raised in the great PNW, he loves spending time with his family and friends outdoors; whether that be boating, fishing, powder days in the mountains, or just riding bikes in the neighborhood with his wife and two daughters.
Todd Cozzens brings to Transformation Capital more than thirty years of experience in the digital health industry that includes founding, operating, building, investing in and exiting innovative and market leading companies. He has a history of creating value both as an operator and as an investor co-founded Transformation Capital and its predecessor management company, Leerink Transformation Partners LLC, in 2016 and serves on the boards of two Fund I portfolio companies: PatientPop and LetsGetChecked (Chairman), and one Fund II company, SWORD. Todd was formerly on the board of PatientPing before its sale to Appriss in 2021 for $500M and on the board of Health Catalyst for 6 years until a year after its IPO in 2019.
Following the acquisition of Picis, Todd joined UnitedHealth Group, the largest commercial health insurer in the world, and helped form its Optum subsidiary, which, today, at over $120 billion in annual revenue, has become one of the most important companies in the digital health landscape, as well as an active acquirer of growth equity-backed digital health businesses.
Before his role in strategy and M&A at Optum, Todd also started a new business unit, Optum Accountable Care Solutions, to enable health systems to bear actuarial risk and transition to value-based care and served as Chief Executive Officer of the unit, which built a revenue base of more than $400 million in 18 months.
Earlier in his career, Todd was the president of a division of Marquette Medical Systems Inc., where he led international sales expansion from 2% to 40% of that company’s revenue. Todd also co-led Marquette Medical’s initial public offering and assisted in its subsequent sale to GE for more than $800 million.
Todd graduated from Marquette University, and completed Harvard Business School’s Program for Management Development.
Prior to founding Define Ventures in 2019, Lynne Chou invested in digital health and connected devices for KPCB since 2013. She works alongside entrepreneurs to develop impactful technologies and therapies for improving patients’ lives.
Before joining KPCB, Lynne had over twelve years of healthcare operating and investing experience. She worked for eight years at Abbott Vascular and Guidant in multiple roles and worked on the launch of over ten interventional cardiology and cardiac surgery product families both in the US and internationally. Lynne also lead the global launch of Absorb, the world’s first bioresorbable vascular scaffold, recognized by WSJ as Medical Device Technology Innovation of the Year and Popular Mechanics. Lynne was responsible for building the global commercial strategy and therapy development as well as playing a key role in the clinical, reimbursement, operational strategy for the therapy.
Lynne earned her BS in industrial engineering from Stanford University and an MBA from Harvard Business School.
Aaron Martin is the Executive Vice President and Chief Digital and Innovation Officer for Providence where he leads Digital, Marketing, and Ventures for Providence. Aaron is also Managing General Partner for Providence Ventures where he is responsible for early stage/venture technology and device investments for the $300M Providence Venture fund.
Aaron has more than 25 years of experience in product, ventures and technology, including leadership of the Amazon teams that transitioned traditional publishing from physical books to Kindle. He has experience as an executive/founder at two venture-backed startups and has held strategy positions at McKinsey & Company. He currently serves on the board of Wildflower Health, Avia, Xealth and Kyruus. He is also a board member of Presbyterian Healthcare Services in New Mexico.
Aaron holds a BS in Economics and Music from Austin College and an MBA in finance and healthcare management from The Wharton School.
Toby Cosgrove, MD, is former CEO and current Executive Advisor of Cleveland Clinic. He is Executive Advisor to Google Healthcare & Life Sciences, Strategic Advisor to Care Centrix, Senior Advisor of Innova Health Partners, and sits on the boards of American Well, and Hims & Hers. As an expert on health issues, he is a frequent commentator in national and international media. As CEO and President of Cleveland Clinic from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). In his role as Executive Advisor, he is working with Cleveland Clinic leadership on strategies for national and international growth.
Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair. He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances.
He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.
Liz invests in healthcare IT, digital health and tech-enabled services for KP Ventures. She joined the fund in 2015. Prior to KPV, Liz ran health impact investing for Imprint Capital, which was acquired by Goldman Sachs. Liz’s operating background is in product development and customer success at the Advisory Board Company (acquired by Optum), TriZetto, and Outcome (acquired by Quintiles).
She completed undergrad at Princeton, and her MBA and MPH at UC Berkeley. Liz has a longstanding love of all things related to people strategy, team culture and career development.
Navid Farzad, is a partner with Frist Cressey Ventures, a Nashville based venture capital firm focused on improving healthcare by partnering with entrepreneurs building transformative organizations.
Prior to FCV, Navid was a partner with Morgan Noble Healthcare Partners, a Washington, D.C. based private investment firm investing in companies determined to transform the delivery of healthcare. In addition, Navid was Chief Strategy Officer of Continuum Health, a physician enablement company that drives better practice efficiency and population health outcomes for medical groups through technology-enabled solutions.
Navid serves on the boards of Audacious Inquiry, DexCare, Klara, Objective Health and Vim as a director or observer. Prior to Morgan Noble, he was with Enhanced Healthcare Partners, a healthcare-focused private equity firm based in New York. Previously, he held positions with Lehman Brothers in the health care investment banking division, Ernst & Young’s Transaction Advisory group, and Arthur Andersen’s health care practice.
Navid holds an MBA from the NYU Stern School of Business and a BA from Loyola University in Maryland.
Gaye joined Mass General Brigham in March 2020 to head up the $30M AI and Digital Innovation Fund (AIDIF) investing in commercial stage digital health companies working with the Mass General Brigham system. She brings more than seven years venture experience investing in healthcare and life sciences companies as a venture partner at Excel Venture Management, where Gaye was an integral part of the investment team and served as board director on several portfolio companies including Qstream, IlluminOss Medical and Lantos Technologies. Prior to joining Excel, Gaye led commercial development for Microbia, Inc, a bio-based chemical company, and earlier was Senior Director of Business Development for Synthetic Genomics. Gaye has more than 18 years of business development experience, focused mainly on developing products and strategic partnerships across several verticals: chemicals, genomics, biobased energy and biobased products.
Gaye received an M.B.A. in Finance and International Management from MIT’s Sloan School and an AB from Harvard and Radcliffe Colleges.
She serves as Governance Chair on the Board of the Pine Street Inn, Boston’s largest homeless shelter.
Gaye joined Mass General Brigham in March 2020 to head up the $30M AI and Digital Innovation Fund (AIDIF) investing in commercial stage digital health companies working with the Mass General Brigham system. She brings more than seven years venture experience investing in healthcare and life sciences companies as a venture partner at Excel Venture Management, where Gaye was an integral part of the investment team and served as board director on several portfolio companies including Qstream, IlluminOss Medical and Lantos Technologies. Prior to joining Excel, Gaye led commercial development for Microbia, Inc, a bio-based chemical company, and earlier was Senior Director of Business Development for Synthetic Genomics. Gaye has more than 18 years of business development experience, focused mainly on developing products and strategic partnerships across several verticals: chemicals, genomics, biobased energy and biobased products.
Gaye received an M.B.A. in Finance and International Management from MIT’s Sloan School and an AB from Harvard and Radcliffe Colleges.
She serves as Governance Chair on the Board of the Pine Street Inn, Boston’s largest homeless shelter.
Derek Streat is Founder, CEO and Chairman of DexCare. He is an accomplished healthcare technology entrepreneur and executive, having co-founded and/or been at the earliest stages of six venture-backed companies including C-SATS (acquired by Johnson & Johnson), Classmates (acquired by United Online), Medify (acquired by Alliance Health Networks) and AdReady (acquired by CPXi).
Prior to joining Providence as an Entrepreneur-in-Residence to commercialize the DexCare platform, Derek served as Vice President of Digital Solutions at Johnson & Johnson - a role he assumed after C-SATS was acquired by the world’s largest healthcare company. There he led the charge to transform the organization responsible for training 250,000 surgeons worldwide into a leading healthcare quality improvement and continuous learning institution that directly advanced patient outcomes, provider efficiency, and health system value through digital solutions.
Derek is also actively involved in national healthcare data transparency efforts for the improvement of patient care as a Co-Founder and Board member of two leading data sharing organizations, PEDSnet and the Improving Renal Outcomes Collaborative (IROC).
